Jeffrey Arnold

Jeffrey Arnold has extensive experience in angel investing and serving as an advisor and director in various companies. From 2006, they were an angel investor for Boston Harbor Angels, Mass Med Angels, and Sky Ventures, leading investments and acting as an investor director in companies such as Smart Cells, Syntonix, and Myomo. Jeffrey also founded Arnold Strategies, LLC in 2005, where they served as President and CEO. Jeffrey has held positions as an investor, advisor, and director in companies like Dermal Photonics, Xeno Biosciences, and Astrocyte Pharmaceuticals. Additionally, they have been a mentor for MIT Venture Mentoring Society and a member of the Board of Advisors for the Museum of Science. Their expertise includes strategic advising and chairing roles in companies like Glympse Bio, Inc. and First Light, Bio Sciences. Furthermore, they were an investor, director, and chairman for Corbus Pharmaceuticals, involved in the development of a non-psychotropic THC synthetic analog for various diseases.

Jeffrey Arnold attended Massachusetts Institute of Technology from 1967 to 1972 where they pursued a Bachelor of Science degree in Electrical Engineering.